Our observations indicated that PTX-Herceptin-MNPs-Fe3O4 had the ability to bind to SK-BR-3 cells, and promoted the targeted antitumor effect on HER2-positive breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.